Cystic Fibrosis Foundation 4
4 · BiomX Inc. · Filed May 17, 2024
Insider Transaction Report
Form 4
BiomX Inc.PHGE
Cystic Fibrosis Foundation
10% Owner
Transactions
- Exercise of In-Money
Common Stock, par value $0.0001 per share
2024-05-15$0.00/sh+4,778,265$4,778→ 9,330,580 total - Exercise of In-Money
Warrant to purchase common stock
2024-05-15−4,778,265→ 0 totalExercise: $0.00→ Common stock (4,778,265 underlying)
Footnotes (1)
- [F1]The warrant was exercisable beginning on February 27, 2023, for that number of shares that would not result in the Reporting Person beneficially owning more than 9.99% of the number of shares of common stock then issued and outstanding upon such exercise, and became exercisable in full on May 15, 2024. The warrant does not expire.